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Cysteine string protein α (CSPα) is a vesicle protein located in the presynaptic terminal
of most synapses. CSPα is an essential molecular co-chaperone that facilitates the
correct folding of proteins and the assembly of the exocytic machinery. The absence of
this protein leads to altered neurotransmitter release and neurodegeneration in multiple
model systems, from flies to mice. In humans, CSPα mutations are associated with
the development of neuronal ceroid lipofuscinosis (NCL), a neurodegenerative disease
characterized by intracellular accumulation of lysosomal material. Here, we review the
physiological role of CSPα and the pathology resulting from the homozygous deletion
of the gene or its mutations. In addition, we investigate whether long-term moderate
reduction of the protein produces motor dysfunction. We found that 1-year-old CSPα
heterozygous mice display a reduced ability to sustain motor unit recruitment during
repetitive stimulation, which indicates that physiological levels of CSPα are required for
normal neuromuscular responses in mice and, likely, in humans.
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PROTEIN DESCRIPTION
Cysteine string protein α (CSPα) (Dnajc5) is a highly conserved protein (Figure 1A) typically
associated with the membrane of synaptic vesicles and secretory granules (Zinsmaier et al., 1990).
It contains a DNA-J domain characteristic of Hsp40 co-chaperones. This domain interacts with
the 70 kDa heat shock cognate protein (Hsc70) (Braun et al., 1996) and regulates the refolding
of client proteins (Hennessy et al., 2005). A linker region connects the DNA-J domain with the
cysteine string domain. The cysteine string domain is approximately 25-amino-acids long and
contains 13–15 cysteines, most of them palmitoylated. Palmitoylation is essential to target CSPα to
synaptic vesicles and to promote neurotransmitter release (Arnold et al., 2004). CSPα also contains
a C-terminal domain, the function of which is not well-understood.
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FIGURE 1 | The lack/decrease of CSPα induces structural and functional changes that compromise synaptic maintenance. (A) Functional domains of the
CSPα protein. (B) Synaptic release defects (left) and fraction of motor nerve terminals with multilamellar bodies and vacuoles in electron microscopy profiles (right) vs.
postnatal age in CSPα KO mice. Graphs summarize numerical values in Ruiz et al. (2008, 2014) (left) and in Fernández-Chacon et al. (2004) (right). (C) Two parallel
chaperone pathways promote efficient SNARE complex formation and normal neurotransmission by regulating SNAP25, through CSPα (pathway I), and
synaptobrevin (VAMP2), through α-synuclein (pathway II). The deficit in CSPα produces synaptic dysfunction (Ruiz et al., 2008, 2014; Rozas et al., 2012), whose
severity, age of onset, and time course depend on the amount of functional CSPα available. α-synuclein overexpression, however, can avoid the synaptic pathology
produced by a defect in pathway I by increasing the formation of SNARE complexes (Sharma et al., 2011, 2012a). (D) Hypothetical model of how genetic ablation,
gene mutations, or increased CSPα degradation induce a positive loop of neurotransmitter (NT) release deficit, accumulation of misfolded synaptic proteins, and
neurodegeneration. In humans, it remains unknown to what extent CSPα haploinsufficiency, sequestration of CSPα in aggregates, and aberrant palmitoylation of
CSPα and other proteins contribute to ANCL.
CSPα DEFICIENCY AND SYNAPTIC
DYSFUNCTION
CSPα is not essential for synaptogenesis, but it is required
for normal neurotransmission and neuronal maintenance in
flies (Zinsmaier et al., 1994), worms (Kashyap et al., 2014),
mice (Fernández-Chacon et al., 2004), and humans (Nosková
et al., 2011). Deletion of the CSPα gene in Drosophila produces
an embryonic semilethal phenotype, and flies that survive
to adulthood present neurotransmitter release alterations and
temperature-sensitive paralysis. Synaptic defects in CSPα-null
(CSPα KO) mice start early after birth, and death occurs
before 3 months of age. Both motor and sensory neurons are
affected by the lack of CSPα (Fernández-Chacon et al., 2004;
Schmitz et al., 2006). In motor nerve terminals, the first sign
of functional alteration appears at 2 weeks of age and consists
of repeated bursts of high-frequency spontaneous release (Ruiz
et al., 2008) (Figure 1B). Only 4 days later, the terminal displays
multiple functional alterations such as reduced quantum content,
low release probability, increased short-term facilitation during
repetitive stimulation, and reduced calcium sensitivity of the
secretory machinery (Ruiz et al., 2008, 2014). In addition, the
size of the readily releasable pool of synaptic vesicles is decreased
(Rozas et al., 2012; Ruiz et al., 2014).
CSPα AS A MOLECULAR CO-CHAPERONE
CSPα interacts with several proteins that participate in exo-
/endocytosis, including syntaxin, synaptotagmin, N- and P/Q-
type calcium channels, and dynamin 1 (for a review see
Burgoyne and Morgan, 2015). The functional significance of
many of these interactions is not well established. However,
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one of the best-known functions of CSPα is its role as a co-
chaperone (Chamberlain and Burgoyne, 2000; Zinsmaier, 2010;
Donnelier and Braun, 2014). CSPα interacts with Hsc70 and
together refold client proteins such as SNAP25 (Sharma et al.,
2011, 2012a; Zhang et al., 2012). SNAP25 is required for the
assembly of the SNARE (soluble N-ethylmaleimide-sensitive
factor attachment receptor) complex, formed by synaptobrevin,
syntaxin, and SNAP25, which in turn is essential for exocytosis
and neurotransmitter release (Figure 1C). In CSPα KO mice,
both SNAP25 and SNARE complex levels are reduced by half
(Chandra et al., 2005).
CSPα AND NEURODEGENERATION
In CSPα KO motor nerve terminals, hallmarks of degeneration
(i.e., vacuoles and multilamellar bodies) appear very early
(Fernández-Chacon et al., 2004), even before the evoked
release defects become apparent (Figure 1B, left graphs). The
degeneration is more prominent in cells with high electrical
activity, such as motor neurons, photoreceptors, and GABAergic
neurons (Fernández-Chacon et al., 2004; Schmitz et al., 2006;
García-Junco-Clemente et al., 2010), suggesting that high
synaptic activity potentiates degeneration, which in turn may
increase the release deficit (Figure 1D).
At the molecular level, it has been proposed that SNAP25
reduction plays a major role in neurodegeneration. This
hypothesis is reinforced by the fact that SNAP25 overexpression
in CSPα KO mice prevents neurodegeneration (Sharma et al.,
2012a). Nevertheless, SNAP25 heterozygous mice, with 50% of
the protein, are phenotypically normal and do not develop
neurodegeneration (Washbourne et al., 2002), indicating that
solely reducing functional SNAP25 is not sufficient to produce
the pathology. On the other hand, misfolded SNAP25 could
have a dominant negative effect over the normally folded
protein copies, or ubiquitinated SNAP25 molecules could
accumulate in the proteasome, interfering with its normal
function. Surprisingly, however, the fact that pharmacological
inhibition of the proteasome increases SNAP25 and SNARE
complex levels, and, hence, improves synaptic function in CSPα-
depleted cells (Sharma et al., 2012b), has challenged this last
hypothesis.
Remarkably, neurodegeneration in CSPα KO mice is
prevented when SNARE complexes are increased by the
overexpression of α-synuclein (Sharma et al., 2011, 2012a),
in spite of the fact that SNAP25 levels are not restored and,
presumably, the amount of misfolded SNAP25 is not reduced.
Overexpression of the mutated form of α-synuclein A53T in
CSPα KO mice restores life span and motor function as well
as wild-type (WT) α-synuclein (Chandra et al., 2005). On the
other hand, overexpression of A30P α-synuclein does not rescue
survival, but can transitorily ameliorate the release deficit and the
calcium sensitivity defect in motor nerve terminals of CSPα KO
mice (Ruiz et al., 2014). The partial effect of A30P α-synuclein
is likely due to its limited ability to increase the formation of
SNARE complexes. These findings suggest that two parallel
pathways regulate SNARE complex formation (Figure 1C),
and raise the question of how the neurodegeneration program
is activated in the absence of CSPα. The molecular basis of
the neurodegeneration is unknown, but a possibility is that
neurodegeneration is linked to the reduced ability of the synapse
to form SNARE complexes and, therefore, to the mismatch
between functional demands and efficient release.
CSPα DEFICIENCY IN HUMANS
Neuronal Ceroid Lipofuscinosis (NCLs) constitute a
heterogeneous group of inherited neurodegenerative disorders
characterized by lysosomal accumulation of autofluorescent
ceroid-lipofuscin aggregates in neurons and other cell types.
The clinical symptoms of NCLs include seizures, movement
disorders, cognitive deterioration, and progressive dementia,
followed by a premature death. The majority of NCL cases affect
children, and only 10% of total cases are in adults.
In recent years, two mutations in the gene that encodes
CSPα, DNAJC5, have been linked to the development of adult-
onset NCL (ANCL) (MIM #162350). These mutations consist
of a point mutation (p.L115R) and an in-frame codon deletion
(p.L1161), both affecting dileucine residues located in the
cysteine string domain of CSPα (Nosková et al., 2011). This
domain is highly palmitoylated and mediates the membrane
binding and intracellular targeting of CSPα. Therefore, mutations
in this region may explain the diffuse intracellular localization
of CSPα observed in the neurons of ANCL patients. Moreover,
the mutated forms of CSPα present an increased tendency
to self-associate, forming detergent-resistant aggregates. These
aggregates interfere with WT CSPα proteins, reducing the co-
chaperone function of CSPα in neurons (Nosková et al., 2011;
Greaves et al., 2012; Zhang and Chandra, 2014) (Figure 1D),
which is likely one of the main reasons why the NCL-linked
DNAJC5 gene mutations display an autosomal dominant (AD)
inheritance pattern. Additionally, a dominant effect of mutated
CSPα on the palmitoylation pattern of lysosomal and synaptic
proteins has been suggested as a mechanism for the development
of DNAJC5-linked ANCL (Henderson et al., 2016).
LONG-TERM MODERATE CSPα
DEFICIENCY ALTERS MOTOR
RESPONSES
Interestingly, only homozygous CSPα KO mice present synaptic
defects, while heterozygous mutant mice appear phenotypically
normal up to 3 months of age (Fernández-Chacon et al., 2004).
Given the late onset of AD-ANCL (around 30 years of age),
we studied the motor function of 1-year-old CSPα heterozygous
mice. Motor performance was first assessed with Balance and
Grip Strength tests (Figure 2A). The balance was measured by
placing the mouse on a horizontal pole suspended in the air.
The pole was rotated manually at a constant speed of one
rotation cycle per second (Figure 2A left). The grip strength
test consisted of suspending the mouse from the pole by its
forelimbs (Figure 2A right). In both trials, the amount of time
the mouse remained suspended from the pole (maximum 10 s)
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FIGURE 2 | The neuromuscular function of 1-year-old CSPα heterozygous mice is altered. (A,B) Balance and grip strength tests show no significant
differences between CSPα heterozygous (n = 27) and WT mice (n = 9). The plot illustrates the average values obtained in three replicates/session for each genotype
(Mann-Whitney U test). (C) Representative recordings of CMAPs in a CSPα+/+ mouse after supramaximal stimulation of the sciatic nerve (1st and 15th responses at
different stimulation frequencies). (D) Depression of the neuromuscular responses (CMAP normalized amplitude) is significantly larger in CSPα+/− (n = 25) than in WT
mice (n = 7) during stimulation trains at 20, 50, and 100 Hz. (E) Maximal depression of the neuromuscular response (normalized) at different stimulation frequencies in
CSPα+/− (n = 24–25) and WT mice (n = 7) (Mann-Whitney U test). Either sex experimental mice (C57BL/6 background) were used. The mouse line was kindly
donated by Dr. Südhof. All experiments were performed according to the guidelines of the European Council Directive for the Care of Laboratory Animals. The
protocol was approved by the Ethics Committee for Animal Experimentation of the Junta de Andalucía (ref. 23-11-2015-364).
was measured. Two sessions separated by 1 week were performed
for each test (Figure 2B). Data obtained from the neurological
tests showed no significant differences between WT and CSPα
heterozygous mice, in either balance or grip strength.
Next, the neuromuscular response of CSPα heterozygousmice
was studied using electromyography (EMG). Evoked Compound
Motor Action Potentials (CMAPs) were recorded from the right
lateral gastrocnemius of anesthetized mice. Stimulation needle
electrodes were placed at the sciatic notch and the head of the
fibula (Ruiz et al., 2005). The active recording electrode was
placed in the medial region of the recordedmuscle. The reference
electrode was inserted at the base of the fifth foot phalanx.
The ground electrode was located at the base of the tail. Brief
supramaximal stimulation pulses were applied at 10 Hz (2 s),
20 Hz (1 s), 50 Hz (1 s), and 100 Hz (0.5 s). Representative
recordings of CMAPs registered during the trains are shown
in Figure 2C. The study revealed enhanced depression with
stimulations between 20 and 100 Hz in CSPα heterozygous mice
compared to WT littermates (Figure 2D). The mean maximal
depression was 5% (20 Hz), 12% (50 Hz), and 25% (100 Hz) lower
in CSPα heterozygous than in WT mice, while no significant
difference was observed at 10 Hz (Figure 2E). Remarkably, the
depression in the EMG recordings was similar to that seen in
3-week-old CSPα KO mice (Fernández-Chacon et al., 2004), a
phenotype not observed in CSPα+/− mice up to 3 month of age.
These results indicate that, over time, a moderate reduction of
CSPα expression alters the ability of the neuromuscular system
to respond normally to stimulation.
FUTURE DIRECTIONS
The multiple functions of CSPα range from acting as a
chaperone, participating in the assembly and dissociation of
multi-protein complexes, and regulating Ca2+ sensitivity for
neurotransmitter release. The severe functional and structural
changes that take place in the absence of CSPα in invertebrate
and vertebrate organism models confirm the importance of
this protein in synapse maintenance and neurotransmitter
release. In humans, CSPα mutations are associated with the
development of AD-ANCL, synaptic degeneration, and neuronal
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loss. Therefore, although both the reduction of CSPα expression
and the presence of CSPα mutations are pathogenic to the
synapse, the severity and time course of the neurological
impairments may vary from severe, including premature death,
to mild, depending on the amount of functional CSPα in each
case. The moderate decrease in CSPα and SNARE complexes in
neurons over time could result in motor function impairment
and, in addition, influence the evolution of common age-
related neurodegenerative disorders, such as Alzheimer’s and
Parkinson’s diseases. Future challenges are to identify patients
with reduced levels of molecular chaperones (such as CSPα),
decipher the mechanisms responsible for the molecular deficit,
understand how the homeostasis of the synapse is altered, and
determine to what extent the reduction of the chaperones
influences the severity of associated neurodegenerative
diseases.
AUTHOR CONTRIBUTIONS
Experiments shown in Figure 2 were performed by EL. EL, RR,
and LT conceived and wrote the manuscript.
FUNDING
This work was supported by grants from the Spanish Ministry
of Science and Innovation (BFU2013–43763-P) and the Tatiana
Perez de Guzman Foundation to LT. RR was supported by a
contract from the V Plan Propio of the University of Seville.
ACKNOWLEDGMENTS
We are grateful to Rafael Fernández-Chacón for discussions and
comments on the manuscript.
REFERENCES
Arnold, C., Reisch, N., Leibold, C., Becker, S., Prufert, K., Sautter, K., et al.
(2004). Structure-function analysis of the cysteine string protein in Drosophila:
cysteine string, linker and C terminus. J. Exp. Biol. 207, 1323–1334.
doi: 10.1242/jeb.00898
Braun, J. E., Wilbanks, S. M., and Scheller, R. H. (1996). The cysteine
string secretory vesicle protein activates Hsc70 ATPase. J. Biol. Chem. 271,
25989–25993. doi: 10.1074/jbc.271.42.25989
Burgoyne, R. D., and Morgan, A. (2015). Cysteine string protein (CSP) and its
role in preventing neurodegeneration. Semin. Cell Dev. Biol. 40, 153–159.
doi: 10.1016/j.semcdb.2015.03.008
Chamberlain, L. H., and Burgoyne, R. D. (2000). Cysteine-string
protein: the chaperone at the synapse. J. Neurochem. 74, 1781–1789.
doi: 10.1046/j.1471-4159.2000.0741781.x
Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O. M., and Sudhof, T.
C. (2005). α-synuclein cooperates with CSPα in preventing neurodegeneration.
Cell 123, 383–396. doi: 10.1016/j.cell.2005.09.028
Donnelier, J., and Braun, J. E. (2014). CSPα-chaperoning presynaptic proteins.
Front. Cell. Neurosci. 8:116. doi: 10.3389/fncel.2014.00116
Fernández-Chacon, R., Wolfel, M., Nishimune, H., Tabares, L., Schmitz,
F., Castellano-Munoz, M., et al. (2004). The synaptic vesicle protein
CSPα prevents presynaptic degeneration. Neuron 42, 237–251.
doi: 10.1016/S0896-6273(04)00190-4
García-Junco-Clemente, P., Cantero, G., Gomez-Sanchez, L., Linares-Clemente,
P., Martinez-Lopez, J. A., Lujan, R., et al. (2010). Cysteine string protein-α
prevents activity-dependent degeneration in GABAergic synapses. J. Neurosci.
30, 7377–7391. doi: 10.1523/JNEUROSCI.0924-10.2010
Greaves, J., Lemonidis, K., Gorleku, O. A., Cruchaga, C., Grefen, C., and
Chamberlain, L. H. (2012). Palmitoylation-induced aggregation of cysteine-
string protein mutants that cause neuronal ceroid lipofuscinosis. J. Biol. Chem.
287, 37330–37339. doi: 10.1074/jbc.M112.389098
Henderson, M. X., Wirak, G. S., Zhang, Y. Q., Dai, F., Ginsberg, S.
D., Dolzhanskaya, N., et al. (2016). Neuronal ceroid lipofuscinosis
with DNAJC5/CSPα mutation has PPT1 pathology and exhibit
aberrant protein palmitoylation. Acta Neuropathol. 131, 621–637.
doi: 10.1007/s00401-015-1512-2
Hennessy, F., Nicoll, W. S., Zimmermann, R., Cheetham, M. E., and Blatch, G.
L. (2005). Not all J domains are created equal: implications for the specificity
of Hsp40-Hsp70 interactions. Prot. Sci. 14, 1697–1709. doi: 10.1110/ps.0514
06805
Kashyap, S. S., Johnson, J. R., McCue, H. V., Chen, X., Edmonds, M. J., Ayala, M.,
et al. (2014).Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene
mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform
for neuroprotective drug screening and identifies a SIR-2.1-independent
action of resveratrol. Hum. Mol. Genet. 23, 5916–5927. doi: 10.1093/hmg/
ddu316
Nosková, L., Stranecky, V., Hartmannova, H., Pristoupilova, A., Baresova,
V., Ivanek, R., et al. (2011). Mutations in DNAJC5, encoding cysteine-
string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid
lipofuscinosis. Am. J. Hum. Genet. 89, 241–252. doi: 10.1016/j.ajhg.2011.
07.003
Rozas, J. L., Gomez-Sanchez, L., Mircheski, J., Linares-Clemente, P., Nieto-
Gonzalez, J. L., Vazquez, M. E., et al. (2012). Motorneurons require cysteine
string protein-α to maintain the readily releasable vesicular pool and synaptic
vesicle recycling. Neuron 74, 151–165. doi: 10.1016/j.neuron.2012.02.019
Ruiz, R., Biea, I. A., and Tabares, L. (2014). α-Synuclein A30P
decreases neurodegeneration and increases synaptic vesicle release
probability in CSPα-null mice. Neuropharmacology 76(Pt A), 106–117.
doi: 10.1016/j.neuropharm.2013.08.032
Ruiz, R., Casanas, J. J., Sudhof, T. C., and Tabares, L. (2008). Cysteine
string protein-α is essential for the high calcium sensitivity of
exocytosis in a vertebrate synapse. Eur. J. Neurosci. 27, 3118–3131.
doi: 10.1111/j.1460-9568.2008.06301.x
Ruiz, R., Lin, J., Forgie, A., Foletti, D., Shelton, D., Rosenthal, A., et al.
(2005). Treatment with trkC agonist antibodies delays disease progression in
neuromuscular degeneration (NMD) mice. Hum. Mol. Genet. 14, 1825–1837.
doi: 10.1093/hmg/ddi189
Schmitz, F., Tabares, L., Khimich, D., Strenzke, N., de la Villa-Polo, P.,
Castellano-Munoz, M., et al. (2006). CSPα-deficiency causes massive and rapid
photoreceptor degeneration. Proc. Natl. Acad. Sci. U.S.A. 103, 2926–2931.
doi: 10.1073/pnas.0510060103
Sharma, M., Burre, J., Bronk, P., Zhang, Y., Xu, W., and Sudhof, T. C. (2012a).
CSPα knockout causes neurodegeneration by impairing SNAP-25 function.
EMBO J. 31, 829–841. doi: 10.1038/emboj.2011.467
Sharma, M., Burre, J., and Sudhof, T. C. (2011). CSPα promotes SNARE-complex
assembly by chaperoning SNAP-25 during synaptic activity. Nat. Cell Biol. 13,
30–39. doi: 10.1038/ncb2131
Sharma, M., Burre, J., and Sudhof, T. C. (2012b). Proteasome inhibition
alleviates SNARE-dependent neurodegeneration. Sci. Transl. Med. 4:147ra113.
doi: 10.1126/scitranslmed.3004028
Washbourne, P., Thompson, P. M., Carta, M., Costa, E. T., Mathews, J. R.,
Lopez-Bendito, G., et al. (2002). Genetic ablation of the t-SNARE SNAP-
25 distinguishes mechanisms of neuroexocytosis. Nat. Neurosci. 5, 19–26.
doi: 10.1038/nn783
Zhang, Y. Q., and Chandra, S. S. (2014). Oligomerization of Cysteine String Protein
alpha mutants causing adult neuronal ceroid lipofuscinosis. Biochim. Biophys.
Acta 1842, 2136–2146. doi: 10.1016/j.bbadis.2014.07.009
Zhang, Y. Q., Henderson, M. X., Colangelo, C. M., Ginsberg, S. D., Bruce,
C., Wu, T., et al. (2012). Identification of CSPα clients reveals a role
Frontiers in Neuroscience | www.frontiersin.org 5 February 2017 | Volume 11 | Article 39
Lopez-Ortega et al. CSPα and Synaptic Maintenance
in dynamin 1 regulation. Neuron 74, 136–150. doi: 10.1016/j.neuron.2012.
01.029
Zinsmaier, K. E. (2010). Cysteine-string protein’s neuroprotective role. J.
Neurogenet. 24, 120–132. doi: 10.3109/01677063.2010.489625
Zinsmaier, K. E., Eberle, K. K., Buchner, E., Walter, N., and Benzer, S. (1994).
Paralysis and early death in cysteine string protein mutants of Drosophila.
Science 263, 977–980. doi: 10.1126/science.8310297
Zinsmaier, K. E., Hofbauer, A., Heimbeck, G., Pflugfelder, G. O., Buchner, S., and
Buchner, E. (1990). A cysteine-string protein is expressed in retina and brain of
Drosophila. J. Neurogenet. 7, 15–29. doi: 10.3109/01677069009084150
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Lopez-Ortega, Ruiz and Tabares. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 6 February 2017 | Volume 11 | Article 39
